135 related articles for article (PubMed ID: 21765346)
1. Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis.
Changsirivathanathamrong D; Wang Y; Rajbhandari D; Maghzal GJ; Mak WM; Woolfe C; Duflou J; Gebski V; dos Remedios CG; Celermajer DS; Stocker R
Crit Care Med; 2011 Dec; 39(12):2678-83. PubMed ID: 21765346
[TBL] [Abstract][Full Text] [Related]
2. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
[TBL] [Abstract][Full Text] [Related]
3. Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis.
Zhang D; Ning J; Ramprasath T; Yu C; Zheng X; Song P; Xie Z; Zou MH
Nat Commun; 2022 Oct; 13(1):6371. PubMed ID: 36289221
[TBL] [Abstract][Full Text] [Related]
4. Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen.
Kolawole AO; Hixon BP; Dameron LS; Chrisman IM; Smirnov VV
Arch Biochem Biophys; 2015 Mar; 570():47-57. PubMed ID: 25712221
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Placental Enzyme Indoleamine 2,3-Dioxygenase in Normal and Abnormal Human Pregnancy.
Kudo Y; Sugimoto J
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674162
[TBL] [Abstract][Full Text] [Related]
6. Human indoleamine-2,3-dioxygenase 2 cofactor lability and low substrate affinity explained by homology modeling, molecular dynamics and molecular docking.
Mirgaux M; Leherte L; Wouters J
J Biomol Struct Dyn; 2024 Jun; 42(9):4475-4488. PubMed ID: 37301605
[TBL] [Abstract][Full Text] [Related]
7. Circulating tryptophan metabolites and risk of colon cancer: Results from case-control and prospective cohort studies.
Papadimitriou N; Gunter MJ; Murphy N; Gicquiau A; Achaintre D; Brezina S; Gumpenberger T; Baierl A; Ose J; Geijsen AJMR; van Roekel EH; Gsur A; Gigic B; Habermann N; Ulrich CM; Kampman E; Weijenberg MP; Ueland PM; Kaaks R; Katzke V; Krogh V; Bueno-de-Mesquita B; Ardanaz E; Travis RC; Schulze MB; Sánchez MJ; Colorado-Yohar SM; Weiderpass E; Scalbert A; Keski-Rahkonen P
Int J Cancer; 2021 Nov; 149(9):1659-1669. PubMed ID: 34196970
[TBL] [Abstract][Full Text] [Related]
8. Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation.
Muller AJ; Mandik-Nayak L; Prendergast GC
Immunotherapy; 2010 May; 2(3):293-7. PubMed ID: 20635895
[No Abstract] [Full Text] [Related]
9. Kynurenine Pathway in Respiratory Diseases.
Pamart G; Gosset P; Le Rouzic O; Pichavant M; Poulain-Godefroy O
Int J Tryptophan Res; 2024; 17():11786469241232871. PubMed ID: 38495475
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease.
Konje VC; Rajendiran TM; Bellovich K; Gadegbeku CA; Gipson DS; Afshinnia F; Mathew AV;
Clin Kidney J; 2021 Apr; 14(4):1097-1105. PubMed ID: 34094518
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder.
Davies NW; Guillemin G; Brew BJ
Int J Tryptophan Res; 2010; 3():121-40. PubMed ID: 22084594
[TBL] [Abstract][Full Text] [Related]
12. Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders.
Kondo T; Okada Y; Shizuya S; Yamaguchi N; Hatakeyama S; Maruyama K
Eur J Cell Biol; 2024 May; 103(2):151418. PubMed ID: 38729083
[TBL] [Abstract][Full Text] [Related]
13. Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Lovelace MD; Varney B; Sundaram G; Lennon MJ; Lim CK; Jacobs K; Guillemin GJ; Brew BJ
Neuropharmacology; 2017 Jan; 112(Pt B):373-388. PubMed ID: 26995730
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan pathway catabolites (serotonin, 5-hydroxyindolacetic acid, kynurenine) and enzymes (monoamine oxidase and indole amine 2,3 dioxygenase) in patients with septic shock: A prospective observational study versus healthy controls.
Troché G; Henry-Lagarrigue M; Soppelsa F; Legriel S; Yehia A; Bruneel F; Bédos JP; Spreux-Varoquaux O
Medicine (Baltimore); 2020 May; 99(19):e19906. PubMed ID: 32384433
[TBL] [Abstract][Full Text] [Related]
15. An expanding range of targets for kynurenine metabolites of tryptophan.
Stone TW; Stoy N; Darlington LG
Trends Pharmacol Sci; 2013 Feb; 34(2):136-43. PubMed ID: 23123095
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review.
Gallagher K; Catesson A; Griffin JL; Holmes E; Williams HRT
J Crohns Colitis; 2021 May; 15(5):813-826. PubMed ID: 33175138
[TBL] [Abstract][Full Text] [Related]
17. Non-targeted UHPLC-MS metabolomic data processing methods: a comparative investigation of normalisation, missing value imputation, transformation and scaling.
Di Guida R; Engel J; Allwood JW; Weber RJ; Jones MR; Sommer U; Viant MR; Dunn WB
Metabolomics; 2016; 12():93. PubMed ID: 27123000
[TBL] [Abstract][Full Text] [Related]
18. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.
Zhang J; Liu Y; Zhi X; Xu L; Tao J; Cui D; Liu TF
Inflamm Res; 2024 Jun; 73(6):979-996. PubMed ID: 38592457
[TBL] [Abstract][Full Text] [Related]
19. Circulating N-lactoyl-amino acids and N-formyl-methionine reflect mitochondrial dysfunction and predict mortality in septic shock.
Rogers RS; Sharma R; Shah HB; Skinner OS; Guo XA; Panda A; Gupta R; Durham TJ; Shaughnessy KB; Mayers JR; Hibbert KA; Baron RM; Thompson BT; Mootha VK
Metabolomics; 2024 Mar; 20(2):36. PubMed ID: 38446263
[TBL] [Abstract][Full Text] [Related]
20. The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer.
Shadboorestan A; Koual M; Dairou J; Coumoul X
Int J Tryptophan Res; 2023; 16():11786469231185102. PubMed ID: 37719171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
